BD Oncomark™ Anti-Human Kappa FITC/Lambda PE/CD19 PerCP-Cy™5.5
Description
The Anti-Kappa antibody, clone TB28-2, is derived from hybridization of P3- X63- Ag8.653 mouse myeloma cells with cells from CB6 (BC57b x BALB/c) mice immunized with human IgG-κ myeloma protein. The Anti-Lambda antibody, clone 1-155-2, is derived from hybridization of P3-X63- Ag8.653 mouse myeloma cells with cells from BALB C/J mice immunized with human IgA1-λ myeloma protein. The CD19 antibody, clone SJ25C1, is derived from the hybridization of Sp2/0 mouse myeloma cells with spleen cells isolated from BALB/c mice immunized with NALM1 + NALM16 cells. Anti-Kappa is specific for kappa light chains of human immunoglobulins. Anti-Lambda is specific for lambda light chains of human immunoglobulins. CD19 (SJ25C1) recognizes a 90-kilodalton antigen that is present on human B lymphocytes.
Preparation And Storage
Store vials at 2°C–8°C. Conjugated forms should not be frozen. Protect from exposure to light. Each reagent is stable until the expiration date shown on the bottle label when stored as directed.
| Description | Clone | Isotype | EntrezGene ID |
|---|---|---|---|
| N/A | N/A | IgG1, ,IgG1, λ,IgG1, κ | N/A |
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.
Although not required, these products are manufactured in accordance with Good Manufacturing Practices.